Objective: To assess the predictive diagnostic added value of positron emission tomography (PET) in preoperative epilepsy surgery evaluation for patients with temporal lobe epilepsy (TLE). Methods: A meta-analysis of publications from 1992 to 2006 was performed. Forty-six studies were identified that met inclusion criteria presenting detailed diagnostic test results and a classified postoperative outcome. Studies exclusively reporting on patients with brain tumors or on children were excluded. Results: The analyses were complicated by significant differences in study design and often by lack of precise patient data. Ipsilateral PET hypometabolism showed a predictive value of 86% for good outcome. The predictive value was 80% in patients with normal MRI and 72% in patients with non-localized ictal scalp EEG. In a selected population of 153 TLE patients with a follow-up of >12 months PET correlated well with other non-invasive diagnostic tests, but none of the odds ratios of any test combination was significant. Conclusion: Our data confirm that ipsilateral PET hypometabolism may be an indicator for good postoperative outcome in presurgical evaluation of drug-resistant TLE, although the actual diagnostic added value remained questionable and unclear. PET does not appear to add value in patients localized by ictal scalp EEG and MRI.
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Summary
Objective: To assess the predictive diagnostic added value of positron emission tomography (PET) in preoperative epilepsy surgery evaluation for patients with temporal lobe epilepsy (TLE). Methods: A meta-analysis of publications from 1992 to 2006 was performed. Forty-six studies were identified that met inclusion criteria presenting detailed diagnostic test results and a classified postoperative outcome. Studies exclusively reporting on patients with brain tumors or on children were excluded. Results: The analyses were complicated by significant differences in study design and often by lack of precise patient data. Ipsilateral PET hypometabolism showed a predictive value of 86% for good outcome. The predictive value was 80% in patients with normal MRI and 72% in patients with non-localized ictal scalp EEG. In a selected population of 153 TLE patients with a follow-up of >12 months PET correlated well with other non-invasive diagnostic tests, but none of the odds ratios of any test combination was significant. Conclusion: Our data confirm that ipsilateral PET hypometabolism may be an indicator for good postoperative outcome in presurgical evaluation of drug-resistant TLE, although the actual diagnostic added value remained questionable and unclear. PET does not appear to add value in patients localized by ictal scalp EEG and MRI.
Introduction
A recent randomized controlled trial confirmed the longstanding observation that surgery is superior to prolonged medical therapy in refractory temporal lobe epilepsy (TLE). 1 The precondition for a successful operation is the careful, precise identification of the operationally defined epileptogenic zone (EZ), 2 removal of which is expected to lead to seizure freedom in a majority of patients. [3] [4] [5] A previous meta-analysis has described several predictive factors for surgical outcome. 6 Nonetheless, the decision algorithm for epilepsy surgery is generally based on empirical and center-specific logistics. In the last two decades, many epilepsy surgery centers have been developed world-wide with a variety of center-specific diagnostic protocols. [7] [8] [9] [10] [11] [12] [13] [14] [15] Today, most cases can be diagnosed non-invasively, in particular when showing a concordant EEG and MRI focus. 16, 17 Nevertheless, when the results from non-invasive investigations are contradictory, some patients still have a need for invasive intracranial EEG recording (DEEG), with associated increased costs and the risk of complications. 18, 19 Thus, the search for non-invasive and cost-effective means of seizure localization has been an important and complex field of research.
Positron emission tomography (PET) has been used for more than 25 years to assist in the localization of epileptic foci. [20] [21] [22] [23] It is a versatile nuclear method capable of providing dynamic information regarding both local and general metabolism in the brain. 24 Glucose metabolism is the most commonly measured parameter using 18 F-fluorodeoxyglucose (
F-FDG).
The characteristic finding in epilepsy is a regional reduction in glucose uptake (hypometabolism) during the interictal state. A significant increase during ictal seizure activity has been reported. 24, 25 There seems to be a significant relation between the time of the last seizure and the degree of observed regional hypometabolism in epilepsy patients. 26 The exact reasons for the interictal hypometabolism are still unclear. 27 A common clinical presumption suggests that cerebral hypometabolism reflects neuronal cell loss, however, in epilepsy patients hypometabolism more closely reflects the degree of cerebral dysfunction than it does actual structural compromise, part of which may be due to loss of synaptic inputs, in addition to the electrical activity generated within the dysfunctional cortex. 24 In this regard, extension of hypometabolism to regions beyond the temporal lobe is often seen in patients with TLE. 10, 28 Therefore, PET images of regional hypometabolism should be interpreted as presenting evidence of a dysfunctional neural network.
By identifying and combining all available literature data from January 1992 to June 2006, we aimed to identify the additional preoperative value of interictal 18 F-FDG PET in the decision making process for epilepsy surgery in patients with TLE.
Methods
An extensive computer literature search using ''Medline'' and ''PubMed'' was performed. Key words were ''Epilepsy surgery'', ''Epilepsy surgery positron emission tomography'', ''Epilepsy surgery PET'', ''Epilepsy surgery outcome''. Each content list of the journals identified by the publications was used for a hand search. Literature reviews and the reference lists of each publication were taken to extend the search. The search was updated during data analysis using a ''PubMed-Crawler''. All such identified publications were considered and read in the full text version.
The following inclusion criteria were defined: We obtained a summary of group analyses and a new selected patient-based meta-analysis and ensured that none of the patients was selected twice by considering only the best documented or the largest study published from each epilepsy center.
In a first step, the correlation values of the studies were collected and the different findings of the studies summarized to non-weighted overall correlation values with the accepted single reference methods and to overall positive predictive values (PPVs).
The following catalogue of diagnostic settings was defined for the reference methods: The PET findings were considered as localizing when PET showed a concordant focus with the reference method ipsilateral to the surgical side. PPVs were calculated as ipsilateral findings of the assessed method with good outcome concordant to the surgical side or/and reference method. It had to be clear from the papers that all patients actually underwent epilepsy surgery after the presurgical evaluation. Otherwise, when extraction and reconstruction of surgical patients was not possible, values were neglected for the overall correlations.
In a second step, a patient-based meta-analysis was created when the studies provided detailed case information for each individual patient. For this attempt, data from group analyses were not sufficient. Individual patients with a follow-up of at least 12 months, with an age of at least 18 years and without mass lesions were selected for a new study population. In this meta-analysis, the results of ictal EEG, MRI, PET and, when available, DEEG were collected for each patient together with postoperative outcome.
Firstly, inter-diagnostic test correlations were obtained to assess the agreement among the tests regardless of surgical side and outcome. In a second step, the findings were categorized as concordant or non-concordant with the surgical side as the standard of reference. The non-concordant group contained non-lateralizing and discordant findings. Then PPVs for outcome were calculated for each diagnostic test and for any two or three test combinations. Outcome was divided into Engel Class I versus Engel Classes II-IV. Lastly, the odds ratios of concordant versus non-concordant findings were calculated for Class I outcome.
Results
From more than 700 citations, we identified 83 potential studies. Forty-six studies were included and 37 had to be excluded. Thirty-five publications analyzed only TLE, whereas 11 reported on a mixture of TLE and extratemporal lobe epilepsy patients.
All studies reported patients well-selected by some criteria. For comparisons of single diagnostic tests and for correlation of correct localization with the final resected side (however determined) was used in 22 studies. In 18 studies, the patients were limited to good outcome (A) for this attempt (see Table 1 for details). In some studies, the FDG PET methods were presumed to be an independently assessed method and the results not taken into the decision for determination of the surgical side. In studies, where the FDG PET findings were taken into the decision process it was not stated or was unclear to what extent they influenced the decision or why they were used. The criteria for localizing or lateralizing findings were rarely described, especially in studies with visual PET image interpretation.
Postoperative follow-up ranged from 3 to 144 months. Outcome classifications used were either the Engel classification or other classifications closely related to or based on the Engel scale. In the overall series, PET study spatial resolution ranged from 2.6 to 8.6 mm in plane at full width halfmaximum, the tracer injection dose from 1 to 15 mCi, and the time for data acquisition after tracer injection from 5 to 60 min. Visual assessment was described in 35 of the studies, visual assessment and additional quantification in 11 and quantification exclusively in 8 studies. The time of last seizure occurrence before scanning was stated in only four studies [29] [30] [31] 71 among the 41 papers published after 1994. Twenty-four different epilepsy centers reported on 18 F-FDG PET. Seven papers came from Seoul, four each from Bethesda, Cleveland, Indianapolis and Melbourne, three from Durham and two from each of Philadelphia, Tampa and Turku.
The identified studies revealed PET as a confirmatory test. The presurgical evaluation protocols of the studies did not identify a uniform procedure. Some authors investigated all patients whereas others only investigated specifically selected patients. Only one study evaluated the impact of PET findings for presurgical evaluation.
32 Table 2 presents the results of the calculated overall correlations of our defined catalogue of diagnostic settings for ipsilateral PET hypometabolism in TLE publications. Concordance values and the PPVs were high for all diagnostic settings reflecting well-selected patients in the publications, e.g. 86.37% of the patients with good outcome had an ipsilateral PET finding. For patients requiring DEEG, and those with non-localizing EEG or normal MRI the The contribution of 18F-FDG PET in preoperative epilepsy surgery 511 It was not possible to distinguish between localizing and lateralizing findings, because this information was too often hidden, not separated or considered as the same in the identified studies. Also, for normal or non-localizing PET findings analyses could not be performed, because most investigators placed little attention on and did not state clearly the outcome in this subgroup.
The significance of ''false'' PET findings, e.g. extratemporal or contralateral temporal, in the otherwise well-localized TLE patients could not really be determined, with presented cases very rare. Only six studies [33] [34] [35] [36] [37] [38] with 131 temporal surgery patients together reported nine patients (6.87%) with ''false'' PET findings. Two studies 33, 37 found one such patient each with poor outcome. The remaining studies included only patients with good outcome, so that seven patients had a good postoperative outcome. Two case reports 39, 40 showed another four separately reported patients with good outcome falsely localized by PET. Carne et al. 68 reported an MRI-negative patient with a false PET finding and good postoperative outcome. Furthermore, two non-localized PET patients with normal MRI had a good postoperative outcome. 68 Selected TLE population In the 153 patients, regardless the final defined surgical side and surgical outcome, the ictal scalp EEG was in agreement with MRI in 106 patients (69.3%). Nineteen patients with a non-localizing ictal scalp EEG showed a localizing MRI in 15 (78.9%) cases, whereas ictal scalp EEG showed a focus in 24 of 28 (85.7%) patients with normal MRI. Four patients with bitemporal MRI abnormalities had a localized focus on EEG. Disagreement between EEG and MRI was seen in only four patients.
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Parker et al. In the 41 DEEG patients, ictal scalp EEG agreed with DEEG in 22 cases (53.4%). All 18 normal or nonlateralized ictal scalp EEG seizure activity was lateralized to one side by DEEG. There was agreement among DEEG and MRI in 32 (78%) patients and disagreement in one patient. In all eight patients with normal MRI scans seizure activity was detected by DEEG. Agreement between PET and DEEG was found in 19 (46.3%) patients. DEEG lateralized seizure activity to one side in all nine normal PET patients. Disagreement was seen in three patients. Table 3 shows the statistics for these inter-diagnostic test correlations. Cohen's Kappa showed moderate agreement among the non-invasive tests.
All diagnostic tests correlated well with the final defined surgical side as seen in Table 4 . Apart from the subgroup of 41 DEEG cases, most concordant cases were detected by ictal scalp EEG, followed by PET and then by MRI. Discordant findings were infrequent, but mostly found at PET or MRI.
The PPVs of single concordant findings for Class I outcome were high and in a similar range for all non-invasive tests including PET. PPVs for concordant two test combinations and in cases of nonconcordant plus concordant findings were also high ( Table 5 ). The PPVs for the non-lateralizing noninvasive tests were 68.4% (13/19) for EEG, 68.8% (22/32) for MRI and 77.3% (17/22) for PET. Surprisingly, against general clinical experience, all cases with non-invasive discordant findings at any test had a Class I outcome. PPV for the all concordant EEG, MRI and PET combination was 77% (67/87). If the ictal EEG was non-concordant in this three tests combination and MRI and PET were concordant the PPV was 91.7% (11/12) . For a non-concordant MRI or PET finding, the PPVs were 83.3% (20/24) and 86.6% (13/15), respectively. The overall PPV of a concordant PET finding was 77.5% (31/40) when MRI or EEG or even both were nonconcordant.
The odds ratios of concordant versus non-concordant findings for Class I outcome are demonstrated 514 O. Willmann et al. in Fig. 1 . Patients with a concordant PET scan had a 0.8 better chance to become seizure-free than patients with a non-concordant PET scan, but the 95% CI ranged from 0.279 to 2.322 and was not significant. When EEG and MRI were both nonconcordant, in these four patients with poor outcome three patients had a concordant PET and one a non-lateralizing PET scan. The overall odds ratio for PET was 1.292 [0.282-5.908] for cases when either EEG or MRI was non-concordant and the other test was concordant, or even when both tests were non-concordant.
The contribution of 18F-FDG PET in preoperative epilepsy surgery 515 Due to the fact that the individual studies on the preoperative evaluation for epilepsy surgery often presented a small number of patients we conducted a meta-analysis. Drawing on patients studied in many trials a meta-analysis has the power to detect small but clinically significant effects and can give more precise estimates of the size of any effects uncovered. This is especially important if we want to look for beneficial or deleterious effects in a specific subgroup of patients.
For understanding meta-analyses, it is important to consider that a meta-analysis is always only as good as the quality of the underlying studies. The method has to be performed with extreme caution, because there is plenty of scope for biases. Because of the mixing of diverse studies, heterogeneity is an unavoidable fact of meta-analysis. The question is not whether it is present but whether its extent seriously undermines the conclusions being drawn.
Our identified individual studies showed huge heterogeneity and many discrepancies. The most important difficulty in performing our meta-analysis was that the data of the individual studies were not presented in an obvious and extractable way to create detailed subgroups. The information about age, follow-up and the results of the diagnostic tests was often hidden. Retrospectively, the connection of the diagnostic test results to outcome could often not be obtained. The interesting subgroup of nonlocalizing findings at any diagnostic test was underrepresented in the individual studies. These patients were often not compared to outcome or to the results of any other diagnostic test. However, this information is needed to calculate odds ratios. Furthermore, detailed presentation of the patients was not available in all studies.
Unfortunately, it was thus only possible to summarize the results of the single studies in an unweighted way. However, it was possible to create a specific patient-based TLE study population from the individual studies.
All studies clearly revealed the confirmatory use of PET. Concordance to any standard reference or to DEEG was quite good in the well-localized TLE patients. PPVs of PET for good outcome are high in TLE patients. This was supported by our un-weighted summarizing of the studies. Even in patients with normal MRI or non-localizing ictal scalp EEG findings concordance and PPVs for good outcome were high with PET. Our selected TLE population showed that all PET findings associated with good outcome had similar high PPVs. All other non-invasive tests represented similar percentages. The distribution of findings was similar among good and bad outcome patients. No specific combination of the tests had a significant odds ratio apart from the combination of non-concordant EEG plus concordant MRI. However, the number of patients with this constellation was low, and so may not be representative. High intertest agreement was observed, and many complementary findings of other tests were observed when one test was normal or non-localizing.
Hypometabolism is neither specific for epilepsy nor for underlying hippocampal sclerosis or any other underlying pathologic lesion. 50, 55, 57, 58 The area of hypometabolism often shows greater extent than foci demonstrated by EEG or MRI. 53, 59 Although PET is the most sensitive diagnostic method, it provides only approximate localization of the EZ and is not adequate for precise localization. 43 It may be useful for differentiating between TLE of mesial or lateral origin. 60 Temporal hypometabolism of the mesial temporal lobe may be a better predictor for seizure control than lateral temporal hypometabolism. 61 Furthermore, hypometabolism over the uncus or in the anterolateral lobe have been reported as independent predictors. 30, 62 Patients with restricted temporal hypometabolism were described to be more likely seizure-free in two studies, 30, 54 although Radtke et al. 58 disagreed and found a greater extent beyond the temporal lobe to be predictive for good outcome. A more recent study 63 indicated the pattern of hypometabolism in a specific network to achieve better prediction than hypometabolism in a single temporal region. The value for defining the extent of the surgical resection and for the decision whether an en bloc anterior temporal lobectomy or a selective mesial resection should be performed remains unclear. 53 PET did not provide any new information in patients well-localized by ictal scalp EEG and concordant MRI, 64, 65 and can even confuse the picture when showing misleading findings contralateral to the EZ in patients rendered seizure-free with surgery, although misleading cases are rare and sometimes due to performance of the test during the ictal state. 39, 40 Newer studies [66] [67] [68] [69] 73 have shown that epilepsy surgery is a successful treatment in TLE patients with normal MRI because of good postoperative seizure control, even without the localization aid of PET. 67 The use of PET for patients with normal MRI has been discussed by several authors. PET investigators stressed the role of PET as a complementary tool to MRI and the procedure of choice for MRI-negative TLE patients. 32, [34] [35] [36] [37] 42, 43, 47, 49, 50, 54, 55, 59, 64, 65, [68] [69] [70] [71] [72] [73] The selective use in normal MRI patients was recommended to reduce costs. 34, 36, 41, 47 Performance based on the affordability to patients was suggested. 36 For PET, we found a PPV of 80% in the group analysis and 71% in the patient-based meta-analysis in the setting of MRI-negative TLE patients. This finding was supported by recent studies 68, 69, 71, 73 with a study population restricted to patients with normal MRI. For our analyses, those studies had to be excluded for the calculation of values because of unextractable data regarding diagnostic test results and outcome, and furthermore because of included studies published from the same epilepsy center. Significant more widespread hypometabolism was found in MRI-negative PET-positive TLE patients. 68 Also, localization by PET and interictal scalp EEG has been shown to be significantly related to seizure-free outcome in patients with normal MRI. 71 In only one study was the actual clinical impact of PET assessed in TLE patients with non-localizing scalp EEG or normal MRI. 32 PET added information in these cases and yielded independent prognostic information from that provided by MRI.
It has also been reported that PET frequently showed bitemporal hypometabolism (BTH) in patients with conflicting scalp EEG and MRI findings, associated with worse outcome. It was recommended that BTH should be an indication for DEEG and a contraindication to perform surgery on noninvasive evaluation alone. 74 Unilateral PET temporal hypometabolism shows excellent correlation with ictal seizure onset on scalp or invasive EEG. 61 Although temporal hypometabolism is not specific for epilepsy, the finding of unilateral temporal hypometabolism has a high probability for the patient having unilateral TLE. 57 So patients with normal, non-localizing, non-lateralizing or even incorrect ictal scalp EEG could benefit from interictal PET. 32, 35, 42, 43, 49, 52, 57, 59, 65, 72 Ictal EEG may be unnecessary or might even provide misleading information, when PET and MRI show localization consistent with interictal EEG. 75 However, EEG data are still mandatory for surgery planning. PET was capable of distinguishing frontal and temporal foci in a study of patients with lateralized but not localized surface ictal video EEG. 75 In patients with interictal bitemporal epileptiform discharges PET is of reduced value as compared to unilateral epilepsy and should be performed as an adjunct to DEEG. 33 Lateralizing convergent PET did not substantially increase the probability of successful postoperative outcome in these patients. Two studies suggested the use of DEEG in patients with misleading MRI or PET, the latter findings indicating poor prognosis, whereas normal findings did not 33, 64 . DEEG is the gold standard in difficult or conflicting cases of non-invasive evaluation. Almost all PET investigators performed DEEG in these cases. The relationship of PETwith respect to DEEG is not clear from the studies, although here it was presumed by the studies that it could reduce the need for DEEG. 49, 76 Since the integration of PET and volumetric MRI in the routine presurgical work-up at the epilepsy center in Indianapolis, DEEG was performed less and better outcomes were achieved as compared to the time period before introduction of PET. 56 Theodore et al. 76 stated that it is difficult to determine how decisions would have been altered on the basis of PET, but it might have been unnecessary to implant the right hemisphere in three patients who had right sided and in five patients who had bilateral subdural electrodes, reducing the total number of hemispheres implanted from 18 to 10 and patients implanted from 13 to 10. The presence of hypometabolism when performed in patients who underwent DEEG was related to better outcome, in contrast to the scalp EEG subgroup. Greater inferior lateral temporal hypometabolism asymmetry was an independent predictor for seizure freedom. 75 Furthermore, patients with PET hypometabolism requiring DEEG were more likely to become seizure-free after surgery compared to patients with a normal PET scan. 54, 58, 77 However, the need for DEEG, in itself, is associated with a greater likelihood for poor prognosis. 33, 77 The value for planning invasive recording was recommended in TLE. 35, 49, 59 PET could help to exclude additional extratemporal foci in TLE. 49 To draw conclusions from this work is quite difficult and there remains a lack of clear evidence. There is no accepted gold standard for localization of the EZ. The most accepted might be DEEG, but it is not reasonable to perform DEEG in all patients due to the previously stated reasons. Good outcome is the goal of the presurgical evaluation. The reported number of patients with poor outcome was low. Reasons for a non-favorable outcome in patients seemingly well-localized can be an incorrectly localized focus, an undetected additional focus, insufficient postoperative drug treatment, or that the surgeon could not or did not resect enough tissue, e.g. in so-called ''eloquent'' brain areas.
The distribution of findings is similar within the good and poor outcome patients. In other words, non-localizing or discordant findings do not necessarily mean a patient will not become seizure-free, and vice versa. The explanation for a discordant abnormality might be that there exist independent seizure foci, that the finding reflects seizure spread or that the technical performance of the procedure was flawed. Discordant findings were rare in these papers, although whether this reflects truly rare occurrences in the population or underreporting is unclear.
The evaluation process is a consensus. Higher concordance gives greater certainty that the EZ is focal. Dellabadia et al. 41 showed a trend to better outcome when three tests are concordant. Labiner et al. 78 found that concordance becomes significant when four tests or more are used and assessed. It was suggested that no non-invasive test should be considered as redundant. 77 However, when a given test has a high diagnostic accuracy but correlates well with other tests, the test in question might not provide any additional corroborating information and could arguably not be considered as a confirmatory test. 79 No single test is solely sufficient to make the localization diagnosis for epilepsy surgery. 72 For PET, values clearly differ among TLE and extratemporal lobe epilepsy. The value of the greater extent of abnormality found on PET remained unclear. The guidance for DEEG is questionable and not proven with respect to considerations of cost-effectiveness. Also, evolution in neuroimaging techniques has to be considered, e.g. an MRI that was evaluated as normal 6 years ago might be judged as localizing today with better high-resolution MRI. Therefore, caution is required regarding this point when spanning early MRI data.
In conclusion, ipsilateral PET hypometabolism showed high concordance and high predictive values for good outcome, even in cases requiring DEEG with normal MRI or with non-localizing ictal scalp EEG. Our data confirm that ipsilateral PET hypometabolism may be an indicator for good postoperative outcome in the presurgical evaluation of drug-resistant temporal lobe epilepsy, although under cost-effectiveness aspects the role and value remain questionable and unclear. PET does not appear necessary in patients localized by ictal scalp EEG and MRI. Larger prospective multicenter studies with a specific question, e.g. the utility of PET in patients with non-localizing ictal scalp EEG and/or MRI should be obtained.
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